Oakworth Capital’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VF
AT
CISOA
DJSG
MIF
CIM
Oakworth Capital's RMD Position: Q2 2026 in Review
Oakworth Capital opened a new position in ResMed (RMD) in Q2 2026: 50 shares worth $9.74K. The stake represents ﹤0.01% of the portfolio and ranks #700 among its holdings. This is a return to the name: Oakworth Capital previously reported a position in RMD as recently as Q4 2025.
Oakworth Capital first reported a position in RMD in Q3 2021 and has held it in 19 quarters since. The position peaked at $21K in Q1 2023. 196 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Oakworth Capital held 50 shares of ResMed worth $9.74K as of Q2 2026.
- ResMed was a new Oakworth Capital position in Q2 2026.
- ResMed made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #700 holding.
- Oakworth Capital first reported a position in ResMed in Q3 2021 and has held it in 19 quarters since.
- Oakworth Capital's ResMed position peaked at $21K in Q1 2023.
- 196 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.